美國聯合醫療 UTHR 深 滬
已收盤 09-19 16:00:00 美东时间
417.57
+7.700
+1.88%
華盛通- 最 高419.26
- 今 開408.75
- 成交量 212.43万股
- 最 低 408.75
- 昨 收 409.87
- 總市值 188.35亿
- 52周最高 436.95
- 市盈率 靜 16.95
- 換手率 4.71%
- 52周最低 266.98
- 委 比 95.25%
- 總股本 4510.66万
- 歷史最高 436.95
- 量 比 3.28
- 振 幅 2.56%
- 歷史最低 36.55
- 每 手 1
- 風險率 51.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
09-11 10:06
Cantor Fitzgerald Maintains Overweight on United Therapeutics, Raises Price Target to $525
Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $405 to $525.
09-10 21:04
Wearable Injectors Market Worth US$18.91 Billion by 2030 With 10.8% CAGR | MarketsandMarkets
DELRAY BEACH, Fla., Sept. 9, 2025 /PRNewswire/ -- The global Wearable Injectors...
09-09 22:15
美股周涨跌榜 | 医药牛股频出！细胞动力周涨幅达50%，新药迎关键进展；美国联合医疗周涨超31%
医药牛股频出！细胞动力周涨幅达50%，新药迎关键进展；美国联合医疗周涨超31%，肺纤维化治疗取得重大突破；Lululemon周跌17%，此前下调年度利润及销售额预期>>
09-06 10:02
Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $414
Wells Fargo analyst Tiago Fauth maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target from $295 to $414.
09-03 21:02
美股牛股 | 医药股彻底疯狂！美国联合医疗飙升近33%，新药迎重大进展；Ionis制药涨近35%
医药股彻底疯狂！美国联合医疗飙升近33%，新药迎重大进展；Ionis制药涨近35%，实验性药物临床数据乐观；MLYS大涨逾80%，高血压新药市场前景广阔>>
09-03 15:53
美股大行评级 | 潜在涨幅91.64%！曼恩凯德生物医疗获HC Wainwright升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持曼恩凯德生物医疗"买入"评级，目标价从9美元升至11美元；杰富瑞：维持Ionis Pharmaceuticals"买入"评级，目标价从83美元升至96美元
09-03 10:20
Why Is United Therapeutics Stock Rallying On Tuesday?
United Therapeutics' Tyvaso showed significant lung function improvement in IPF patients, with plans to seek FDA approval for expanded use.
09-02 22:59
United Therapeutics Stock (UTHR) Rockets 40% on Clinical Trial Results
United Therapeutics stock surged on Tuesday after it reported positive Phase 3 ...
09-02 21:55
MannKind Amends License Agreement with United Therapeutics
MannKind ( ($MNKD) ) just unveiled an announcement. On August 24, 2025, MannKin...
08-27 20:28
